ArticleEndocrine2026
Distinct attentional profiles associated with diabetic ketoacidosis and hypoglycemia in pediatric type 1 diabetes: MOXO-CPT assessment.
Article in Endocrine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionType 1 diabetes (T1D) in children and adolescents has been associated with alterations in attentional and executive functioning. Acute metabolic complications, particularly diabetic ketoacidosis (DKA) and clinically significant hypoglycemia (CSH), may adversely affect neurocognitive development. This study evaluated the associations between acute metabolic events and attentional functioning in pediatric patients with T1D. MATERIALS AND
methodsThe study included 117 children and adolescents with T1D (55 females, 62 males; mean age 12.86 ± 3.16 years). Participants were stratified according to the presence of DKA and CSH. Cognitive functioning was assessed using the MOXO Continuous Performance Test (MOXO-CPT), which evaluates sustained attention, timeliness, impulsivity, and hyperactivity. Associations between cognitive performance and clinical variables were analyzed using ANOVA, ANCOVA, and multivariable regression models.
resultsPatients with a history of CSH demonstrated significantly lower sustained attention (p < 0.001) and timeliness scores (p < 0.001) compared with controls. DKA was associated with poorer impulsivity scores (p = 0.008). After adjustment for age, sex, HbA1c, diabetes duration, and treatment modality, the differences in sustained attention and timeliness, whereas the association with impulsivity was attenuated.
conclusionsAcute metabolic complications in pediatric T1D were associated with domain-specific alterations in attentional functioning. CSH was primarily related to impaired sustained attention and timeliness, whereas DKA was associated mainly with impulsivity. Early identification of attentional difficulties may support individualized diabetes care and improve long-term metabolic safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.